New Therapeutic Horizons for Graves' Hyperthyroidism. (2020)

First Author: Lane LC
Attributed to:  Molecular determinants of immune tolerance in Graves' disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1210/endrev/bnaa022

PubMed Identifier: 32845332

Publication URI: http://europepmc.org/abstract/MED/32845332

Type: Journal Article/Review

Volume: 41

Parent Publication: Endocrine reviews

Issue: 6

ISSN: 0163-769X